Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Caladrius Bio (NQ: CLBS )

1.555 USD +0.065 (+4.36%)
Streaming Delayed Price Updated: 2:01 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Caladrius Bio

< Previous 1 2 3 4 Next >
Caladrius Biosciences Announces Orphan Drug Designation for CLBS12 for the Treatment of Buerger’s Disease
From GlobeNewswire News Releases
Caladrius Biosciences to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
From GlobeNewswire News Releases
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time
From GlobeNewswire News Releases
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors
From GlobeNewswire News Releases
Caladrius Biosciences, Inc. Closes $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
From GlobeNewswire News Releases
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
From GlobeNewswire News Releases
Caladrius Biosciences Closes $25.0 Million Private Placement
From GlobeNewswire News Releases
Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021
From GlobeNewswire News Releases
Caladrius Biosciences Announces $25.0 Million Private Placement
From GlobeNewswire News Releases
Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp?
InvestorsObserver issues critical PriceWatch Alerts for CLBS, NIO, BIOL, FCEL, and CCL. 
From PR Newswire
Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction
From GlobeNewswire News Releases
Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021
From GlobeNewswire News Releases
Life Sciences Company Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations 
From GlobeNewswire News Releases
Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com 
From GlobeNewswire News Releases
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
Program strategy and prioritization supports projection of available capital through 2021 
From GlobeNewswire News Releases
Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com 
From GlobeNewswire News Releases
Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference
From GlobeNewswire News Releases
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
The Company retains Robert Honigberg, M.D., as interim Chief Medical Officer 
From GlobeNewswire News Releases
Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020
From GlobeNewswire News Releases
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
Conference call begins today at 4:30 p.m. Eastern time 
From GlobeNewswire News Releases
Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November
From GlobeNewswire News Releases
Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors
From GlobeNewswire News Releases
Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time
From GlobeNewswire News Releases
Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°
From GlobeNewswire News Releases
Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage
From GlobeNewswire News Releases
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa
From GlobeNewswire News Releases
Caladrius Biosciences to Present at the BIO Investor Forum Digital
From GlobeNewswire News Releases
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations 
From GlobeNewswire News Releases
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.